about
Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells.Recurrent Coding Sequence Variation Explains Only A Small Fraction of the Genetic Architecture of Colorectal CancerThe homeobox gene MEIS1 is methylated in BRAF (p.V600E) mutated colon tumors.Tumor LINE-1 Methylation Level in Association with Survival of Patients with Stage II Colon Cancer.Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumors.Chemosensitivity of BRCA1-Mutated Ovarian Cancer Cells and Established Cytotoxic Agents.Promoter methylation and mRNA expression of HLA-G in relation to HLA-G protein expression in colorectal cancer.Characterization of novel low passage primary and metastatic colorectal cancer cell lines.Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study.Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.BRAF mutation-specific promoter methylation of FOX genes in colorectal cancerEvidence for genetic association between chromosome 1q loci and predisposition to colorectal neoplasia.Methylation associated transcriptional repression of ELOVL5 in novel colorectal cancer cell lines.ROS-induced near-homozygous genomes in thyroid cancer.Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia.Imprinted survival genes preclude loss of heterozygosity of chromosome 7 in cancer cells.Associations of polymorphisms of eight muscle- or metabolism-related genes with performance in Mount Olympus marathon runners.In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors.Allelic Switching of , , and during Colorectal Cancer TumorigenesisHLA-G protein expression in colorectal cancer evaluated by immunohistochemistry and western blot analysis: Its expression characteristics remain enigmaticGenomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes
P50
Q35755480-8DA7F337-F9A0-4375-82F9-9F27EE60FF23Q36265886-C3E58333-D448-44EB-A2D8-61E5186F14DCQ37288532-F9E0680C-D4B9-4B15-8950-8D297201D0CEQ37631429-93DE1286-8B61-46D1-BA32-5E41D98647DBQ38652450-1D142045-91DF-43AC-9F25-76099F571087Q38672032-95A4CA84-EED1-40D0-80A7-3CAF7295C071Q38767295-DBCBDF28-A771-489D-9719-ECC4D489F174Q38792685-DB9E2573-D1BB-4EFA-802C-4E05377D05D0Q38839775-C8A365B4-6090-409B-8E61-E9E1505022DAQ40151513-EF540E4A-A5F2-4681-975B-F9F55876307BQ41056167-3A406985-4D67-4FDC-98A0-E8FA63298002Q41532605-3392EA61-00A2-437F-8631-F544F5D440C6Q41911913-A265676B-1988-4ADB-8CBF-A2DCBD34B3CBQ46275699-88AD7EC2-FDE6-4D82-9ECA-2F15C13E992DQ47431964-9B1E6AEB-E7E9-4E21-86BF-9A5F2DA7826AQ48042328-5C5A2FE7-95A0-4BC3-91E0-4B96543186B1Q51140131-E2601C42-3AD5-4633-AD4B-D46659D03D80Q52720551-5D3DE578-6B47-4292-99AA-F7F9F612E119Q64059376-6C9E48D6-F7B8-487E-97AE-92215820F35FQ90082719-6F7F73CA-1726-4D83-BF9D-52BE71B05985Q92303390-DB029F36-B0A9-4D78-A60C-3729B3E6C5FB
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Arnoud Boot
@ast
Arnoud Boot
@en
Arnoud Boot
@es
Arnoud Boot
@nl
Arnoud Boot
@sl
type
label
Arnoud Boot
@ast
Arnoud Boot
@en
Arnoud Boot
@es
Arnoud Boot
@nl
Arnoud Boot
@sl
altLabel
A. Boot
@nl
prefLabel
Arnoud Boot
@ast
Arnoud Boot
@en
Arnoud Boot
@es
Arnoud Boot
@nl
Arnoud Boot
@sl
P106
P1153
57189347792
P2798
P31
P496
0000-0002-7717-7416